GSP Crop Science IPO Day 1: 0.48x Subscribed & GMP Rs. 0

The proceeds of the fresh issue are proposed to be utilised for strategic debt reduction - i.e. repayment/prepayment of borrowings up to Rs. 170 crores as well as general corporate purposes.
Before the public opening, GSP Crop Science successfully raised Rs. 120.00 crores from anchor investors. The total IPO subscription reached 0.48 times on Day 1, and the grey market premium (GMP) held flat at Rs. 0. Here, we will discuss what happened on Day 1 of the GSP Crop Science IPO in detail.
Key dates for the GSP Crop Science IPO
The IPO of GSP Crop Science is open for subscription from March 16, 2026 (today) to March 18, 2026. The IPO allotment will be completed on March 20, 2026. The refunds and shares will be credited to the demat account from March 23, 2026. The shares will be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on March 24, 2026.
The IPO is priced with an upper band of Rs. 320 and a lower band of Rs. 304 per share, with a minimum application lot size of 46 shares and an investment of Rs. 14,720 at the upper band for retail investors. The book running lead managers for this IPO offering include Equirus Capital Private Limited, Motilal Oswal Investment Advisors Limited and the registrar of the issue is MUFG Intime India Pvt. Ltd.
About GSP Crop Science
GSP Crop Science was founded in 1985 and is headquartered in Ahmedabad. Since then, GSP Crop Science has evolved into a robust, research-driven powerhouse in the crop protection space. The company supports the agricultural sector by supplying advanced solutions to help farmers improve agricultural productivity and overall agricultural output. GSP Crop Science conducts business in two primary product engines:
- Formulations: Precisely developed products consisting of active ingredients that target pests, weeds, or diseases and specific additives that improve performance.
- Technicals: Concentrated active ingredients processed and manufactured to make core insecticides, herbicides and fungicides.
Financially, GSP Crop Science had a stellar FY25 with total income rising to Rs. 1,301.06 crores from Rs. 1,158.23 crores in FY24, with Profit After Tax (PAT) jumping to Rs. 81.42 crores from Rs. 55.54 crores in FY24. This momentum successfully carried over into the first half of FY26 (ended September 30, 2025), where the company reported an impressive PAT of Rs. 81.07 crores on a total income of Rs. 847.61 crores. With 524 product registrations and 102 granted patents, GSP is well-placed as a strong player in the agrochemical cycle.
Subscription, GMP, and investor sentiment on day 1
On the first day of the bid, the GSP Crop Science IPO witnessed a heavily polarised response as investors weighed up its debt reduction strategy against broader market cyclicality. At the end of Day 1, the IPO issue had a total subscription of 0.48 times.
Qualified institutional buyers (QIBs) were at the forefront, with their quota subscribed 1.28 times. However, Non-Institutional Investors (NIIs) and Retail Individual Investors (RIIs) were much more restrained in taking an interest with their subscriptions amounting to only 0.29 times and 0.11 times, respectively.
The Grey Market Premium (GMP) of GSP Crop Science was at Rs. 0 at the upper price band of Rs. 320. This represents a tentative listing price of Rs. 320 with a potential listing gain of 0.00%.
Investor sentiment is cautiously neutral regarding the GSP Crop Science IPO. The company's strong patent portfolio, improving bottom line and deleveraging plans are its major strengths. However, the flat GMP and the inherent unpredictability of the agriculture sector (monsoon dependency and global chemical pricing) are leading to caution among retail investors. The market will closely keep an eye on the build-up of the subscriptions before the window closes on March 18, 2026.












